Clinical, Genetic, and Neuropathologic Characteristics of Posterior Cortical Atrophy
Neurol 63:1168-1174, Tang-Wai,D.F.,et al, 2004
Hyperinsulinemia and Risk of Alzheimer Disease
Neurol 63:1187-1192, Luchsinger,J.A.,et al, 2004
Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004
Memory Complaints in Nondemented Men Predict Future Pathologic Diagnosis of Alzheimer Disease
Neurol 63:1960-1961, Jorm,A.F.,et al, 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004
Mixed Dementia, Emerging Concepts and Therapeutic Implications
JAMA 292:2901-2908, Langa,K.M.,et al, 2004
Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004
Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004
Fatal Inflammatory AIDS-Associated PML with High CD4 Counts on HAART: A New Clinical Entity?
Neurol 63:2452-2453, Di Giambenedetto,S.,et al, 2004
Preclinical Alzheimer Disease
Neurol 63:2341-2347, Saxton,J.,et al, 2004
Comparison of Different MRI Brain Atrophy Rate Measures with Clinical Disease Progression in AD
Neurol 62:591-600, Jack, Jr.,C.R.,et al, 2004
Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements
Arch Neurol 61:82-88, Zandi,P.P.,et al, 2004
Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004
Imaging Cerebral Atrophy:Normal Ageing to Alzheimer's Disease
Lancet 363:392-394, Fox,N.C.&Schott,J.M., 2004
The Efficacy of Donepezil in the Treatment of Neuropsychiatric Symptoms in Alzheimer Disease
Neurol 63:214-219,200, Holmes,C.,et al, 2004
Atypical Antipsychotic Drugs in the Treatment of Behavioural and Psychological Symptoms of Dementia: Systematic Review
BMJ 329:75-78, Lee,P.E.,et al, 2004
Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004
Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 291:2947-2958,3005, Shumaker,S.A.,et al, 2004
Hereditary Spastic Paraplegia
Arch Neurol 61:849-855,830, Orlacchio,A.,et al, 2004
Impact of Presymptomatic Genetic Testing for Hereditary Ataxia and Neuromuscular Disorders
Arch Neurol 61:875-880, Smith,C.O.,et al, 2004
Neurobrucellosis:Clinical and Neuroimaging Correlation
AJNR 25:395-401, Al-Sous,M.W.,et al, 2004
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Arch Neurol 61:661-666, Arvanitakis,Z.,et al, 2004
Paraneoplastic "Stiff Person Syndrome" with Metastatic Adenocarcinoma and anti-Ri Antibodies
Neurol 62:1402-1404, McCabe,D.J.H.,et al, 2004
Clinicopath Conf., Progessive Multifocal Leukoencephalopathy
NEJM 350:1884-1893, Case 14-2004, 2004
Size of the Treatment Effect on Cognition of Cholinesterase Inhibition in Alzheimer's Disease
JNNP 75:677-685, Rockwood,K., 2004
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Stiff-Person Syndrome
The Neurologist 10:131-137, Murinson,B.B., 2004
ALS Corticospinal Degeration on DWI
Neurol 62:1834, Cabello,J.P.,et al, 2004
Estimating Prognosis for Nursing Home Residents with Advanced Dementia
JAMA 291:2734-2740, Mitchell,S.L.,et al, 2004
Unilateral Hyperhydrosis in Pourfour du Petit Syndrome
Eur J Cardiothorac Surg 26:456-458, Kara, M.,et al, 2004
Morning Glory Sign: A Particular MR Finding in Progressive Supranuclear Palsy
Magn Reson Med Sci 3:125-132, Adachi, M., et al, 2004
Vasogenic Edema in Bickerstaff's Brainstem Encephalitis
Neurol 61:836-838, Weidauer,S.,et al, 2003
Bickerstaff's Brainstem Encephalitis: Clinical Features of 62 Cases and a Subgroup Associated with Guillain-Barre Syndrome
Brain 126:2279-2290, Odaka,M.,et al, 2003
Donepezil is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease
Am Geriatr Soc 51:937-944, Geldmacher,D.S.,et al, 2003
Exercise Plus Behavioral Management in Patients with Alzheimer's Disease
JAMA 290:2015-2022, Teri,L.,et al, 2003
Benign Calf Amyotrophy
Arch Neurol 60:1415-1420, Felice,K.J.,et al, 2003
Identification of New Presenilin Gene Mutations in Early-Onset Familial Alzheimer Disease
Arch Neurol 60:1541-1544,1521, Tedde,A.,et al, 2003
Loss of Calculation Abilities in Patients with Mild and Moderate Alzheimer Disease
Arch Neurol 60:1585-1589, Martin,R.C.,et al, 2003
Prevalence and Clinical Features of HTLV Neurologic Disease in the HTLV Outcomes Study
Neurol 61:1588-1594, Orland,J.R.,et al, 2003
The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Arch Neurol 60:940-946,923, Morris,M.C.,et al, 2003
Polymyositis Masquerading as Motor Neuron Disease
Arch Neurol 60:1001-1003, Ryan,A.,et al, 2003
ALS Patients on TPPV
Neurol 61:135-137, Hayashi,H. &Oppenheimer,E.A., 2003
Subacute Meningoencephalitis in a Subset of Patients with AD After AB42 Immunization
Neurol 61:46-54,7, Orgogozo,J.M.,et al, 2003
Efficacy of Cholinesterase Inhibitors in the Treatment of Neuropsychiatric symptoms and Functional Impairment in Alzheimer Disease
JAMA 289:210-216, Trinh,N.,et al, 2003
Acetylcholinesterase Inhibitors for Vascular Dementia and Alzheimer's Disease Combined With Cerebrovascular Disease
Stroke 34:584-586, Bowler,J.V., 2003
Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003
Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic Cancer
Medicine 82:216-223, Rojas-Marcos,I.,et al, 2003
Mitochondrial Respiratory-Chain Diseases
NEJM 348:2656-2668, DiMauro,S. &Schon,E.A., 2003